Head of Medical Affairs

Director, Market Access - Cell Therapy 

Senior Scientist, Cell Biology

Director, Commercial Analytics

Finance Manager

Senior Manager/Assoc. Director, Investor Relations and Corporate Communications

Associate Bioprocess Scientist/Engineer I/II (Temporary)

Executive Assistant & Office Manager

Associate Scientist 

Receiving Clerk (Part-time)

Director, Clinical Quality

Manager, GMP Quality Operations

MSAT Scientist II

Principal Bioprocess Scientist/Engineer I/II, Cell Process Development

Director, Cell Therapy HEOR  

Associate Director, Technology Transfer and MSAT

Senior Clinical Project Manager

Patient Logistics Manager (Contractor)

Director, Program Lead 

Research Associate

Payroll Specialist (Sr.)

Scientist

Senior Recruiter

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

8Biomed

A-Alpha Bio

A2 Biotherapeutics

AavantiBio

AB Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

ACELYRIN

Acepodia

Achieve Life Sciences

Acrivon Therapeutics

Acutis Diagnostics

Adagio Therapeutics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

adMare BioInnovations

Admera Health

Adverum Biotechnologies

adyn

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agena Bioscience

Akero Therapeutics

Akouos

Alamar Biosciences

Alector

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

AllStripes

Alltrna

Alpine Immune Sciences

Altis Biosystems

Alto Neuroscience

AltPep

Alumis

Alveo Technologies

ALX Oncology

Alzheon

Ambagon Therapeutics

Amberstone Biosciences

Ambys Medicines

Amylyx

AN2 Therapeutics

Andes

Angiocrine Bioscience

AnHeart Therapeutics

Annexon Biosciences

Ansa Biotechnologies

Antheia

Apollomics

Appia Bio

Applied Molecular Transport

Apriori Bio (Flagship)

Aptevo Therapeutics

Apton Biosystems

Aptose Biosciences

Aquinnah Pharmaceuticals

Arbor Biotechnologies

Arcadia Science

Arcellx

Arcturus Therapeutics

Arcutis Biotherapeutics

Arima Genomics

Ark Biotech

Arkuda Therapeutics

Armata Pharmaceuticals

Aro Biotherapeutics

Arpeggio Biosciences

Arrakis Therapeutics

Arranta Bio

ArsenalBio

Artisan Bio

Artiva Biotherapeutics

Aruvant

Ascidian Therapeutics

Ascribe Bioscience

Arcellx is developing immunotherapies to treat cancer. Chimeric antigen receptor (CAR) T-cells are the latest innovation to identify and eliminate cancer cells, yet there is still more room for improvement. Arcellx’s unique approach involves their novel D-Domain technology, a small, stable, fully synthetic binding agent that can be combined with CARs to improve target specificity and enhance binding affinity. From the D-Domain, Arcellx can generate diverse libraries of proprietary target-binding domains which serve as the foundation of their proprietary ddCAR and ARC-SparX platforms. Arcellx is currently developing cell therapies treatments for multiple myeloma, acute myeloid leukemia and solid tumors, the first of which is now in Phase 2 clinical trials.

<p>Arcellx is developing immunotherapies to treat cancer. Chimeric antigen receptor (CAR) T-cells are the latest innovation to identify and eliminate cancer cells, yet there is still more room for improvement. Arcellx’s unique approach involves their novel D-Domain technology, a small, stable, fully synthetic binding agent that can be combined with CARs to improve target specificity and enhance binding affinity. From the D-Domain, Arcellx can generate diverse libraries of proprietary target-binding domains which serve as the foundation of their proprietary ddCAR and ARC-SparX platforms. Arcellx is currently developing cell therapies treatments for multiple myeloma, acute myeloid leukemia and solid tumors, the first of which is now in Phase 2 clinical trials.</p>


Find a biotech startup job.